Back to Agenda
Session 2: Navigating Advertising and Promotion: Multi-Center Updates from FDA
Session Chair(s)
Twyla Mosey, PHARMD
Acting Office Director, OPDP, CDER
FDA, United States
Gain firsthand insights from FDA experts on compliance priorities and best practices shaping the future of compliant advertising and promotion.
OPDP Updates
Twyla Mosey, FDA
Updates in Advertising & Promotion: FDA CBER APLB
Kristine T. Khuc, FDA
FDA, Center for Veterinary Medicine: FDA Updates and Insights
Christopher Loss, FDA
FDA, Center for Veterinary Medicine: FDA Updates and Insights
Deborah Wolf, FDA
Learning Objective : At the conclusion of this session, participants should be able to:- Identify current compliance priorities in advertising and promotion and explain how these priorities apply across different FDA-regulated product categories
- Analyze recent compliance actions and extract key lessons learned to achieve regulatory compliance
- Describe and implement strategies for continued compliance across FDA-regulated products
Speaker(s)
OPDP Updates
Twyla Mosey, PHARMD
FDA, United States
Acting Office Director, OPDP, CDER
Updates in Advertising & Promotion: FDA CBER APLB
Kristine T. Khuc, PHARMD
FDA, United States
Consumer Safety Officer, CBER
FDA, Center for Veterinary Medicine: FDA Updates and Insights
Christopher M. Loss, DVM
FDA, United States
Supervisory Veterinary Medical Officer (Branch Chief)
Center for Devices and Radiological Health
Deborah Wolf, JD
FDA, United States
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH
Have an account?